WebJournal of Clinical Oncology; JCO Oncology Practice; JCO Global Oncology; JCO Clinical Cancer Informatics; JCO Precision Oncology; ASCO Publications Home; Career Center; ... Issue 23 August 10 2005 (pp. 5279-5415) Issue 22 August 1 2005 (pp. 4809-5277 ... WebJ Clin Oncol 30:2046–2054 CrossRefPubMed Lynch TJ, Bondarenko I, Luft A et al (2012) Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol 30:2046–2054 CrossRef PubMed
Changing Treatment Paradigms for Myelodysplastic …
WebApr 25, 2012 · J Clin Oncol. 2005, 23: 4669-4678. 10.1200/JCO.2005.09.098. Article CAS PubMed Google Scholar Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD: Development of potent monoclonal antibody auristatin conjugates for cancer … WebMar 30, 2024 · J Clin Oncol. 2002; 20:1335–43. [Google Scholar] 10. Edelman ... J Clin Oncol. 2005; 23:190–6. [Google Scholar] 13. Booth CM, Eisenhauer EA. Progression-free survival: meaningful or simply measurable? J Clin Oncol. 2012; 30:1030–3. [Google Scholar] 14. Gajra A, Klepin HD, Feng T, et al. Predictors of chemotherapy dose reduction at first ... handstand poses
Journal Club ESMO
WebMar 5, 2014 · J Clin Oncol. 2005; 23: 105-112. Crossref; PubMed; Scopus (54) Google Scholar; Dose intensification of the doxorubicin, ifosfamide, and dacarbazine regimen—originally developed in the late 1980s—produced no improvement in responses, progression-free survival, or overall survival compared with the standard dose regimen. 24. WebJ Clin Oncol. 2005;23(24):5568–5577. 110. Knoedler M, Dietz A, Gauler TC, et al. Cetuximab, fluorouracil (5-FU), cisplatin, and docetaxel as first-line treatment in patients with … WebOct 16, 2015 · J Clin Oncol. 2005; 23:190-196. Google Scholar Kelly K, Crowley J, Bunn PA, et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non–small-cell lung cancer: a Southwest Oncology Group Trial. J Clin Oncol. 2001;19: 3210-3218. Google Scholar handstand practice